Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1958 1
1981 1
1984 1
1985 2
1986 5
1988 3
1992 1
1993 1
1994 1
1995 2
1996 3
1997 2
1998 3
1999 1
2000 2
2001 1
2002 1
2003 1
2005 1
2006 2
2007 6
2008 2
2009 5
2010 6
2011 2
2012 3
2013 1
2015 1
2016 1
2017 4
2018 3
2019 3
2020 3
2021 10
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of AML Relapse After Allo-HCT.
Webster JA, Luznik L, Gojo I. Webster JA, et al. Front Oncol. 2021 Dec 16;11:812207. doi: 10.3389/fonc.2021.812207. eCollection 2021. Front Oncol. 2021. PMID: 34976845 Free PMC article. Review.
This CAR won't start: predicting nonresponse in ALL.
Webster JA, Luznik L. Webster JA, et al. Blood Adv. 2023 Aug 8;7(15):4215-4217. doi: 10.1182/bloodadvances.2023009776. Blood Adv. 2023. PMID: 37552511 Free PMC article. No abstract available.
The NOAA NCEI marine microplastics database.
Nyadjro ES, Webster JAB, Boyer TP, Cebrian J, Collazo L, Kaltenberger G, Larsen K, Lau YH, Mickle P, Toft T, Wang Z. Nyadjro ES, et al. Among authors: webster jab. Sci Data. 2023 Oct 20;10(1):726. doi: 10.1038/s41597-023-02632-y. Sci Data. 2023. PMID: 37863915 Free PMC article.
Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation.
Pasca S, Haldar SD, Ambinder A, Webster JA, Jain T, Dalton WB, Prince GT, Ghiaur G, DeZern AE, Gojo I, Smith BD, Karantanos T, Schulz C, Stokvis K, Levis MJ, Jones RJ, Gondek LP. Pasca S, et al. Among authors: webster ja. Haematologica. 2024 Mar 1;109(3):948-952. doi: 10.3324/haematol.2023.283886. Haematologica. 2024. PMID: 37731390 Free PMC article. No abstract available.
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
Webster JA, Reed M, Tsai HL, Ambinder A, Jain T, Dezern AE, Levis MJ, Showel MM, Prince GT, Hourigan CS, Gladstone DE, Bolanos-Meade J, Gondek LP, Ghiaur G, Dalton WB, Paul S, Fuchs EJ, Gocke CB, Ali SA, Huff CA, Borrello IM, Swinnen L, Wagner-Johnston N, Ambinder RF, Luznik L, Gojo I, Smith BD, Varadhan R, Jones RJ, Imus PH. Webster JA, et al. Transplant Cell Ther. 2023 Mar;29(3):182.e1-182.e8. doi: 10.1016/j.jtct.2022.12.018. Epub 2022 Dec 29. Transplant Cell Ther. 2023. PMID: 36587740 Free PMC article.
Blood Donors.
Webster JA. Webster JA. Can Med Assoc J. 1942 May;46(5):497-8. Can Med Assoc J. 1942. PMID: 20322459 Free PMC article. No abstract available.
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease.
Sanber K, Ye K, Tsai HL, Newman M, Webster JA, Gojo I, Ghiaur G, Prince GT, Gondek LP, Smith BD, Levis MJ, DeZern AE, Ambinder AJ, Dalton WB, Jain T. Sanber K, et al. Among authors: webster ja. Leuk Lymphoma. 2023 Apr;64(4):846-855. doi: 10.1080/10428194.2023.2173523. Epub 2023 Feb 6. Leuk Lymphoma. 2023. PMID: 36744656
91 results